INTRODUCTION
b-Arrestins, namely b-arrestin1 and b-arrestin2, play fundamental roles in G protein-coupled receptor (GRCR) desensitization and internalization in an agonist-dependent manner (Lefkowitz and Whalen, 2004) . Besides, these multifunctional adaptor proteins can mediate the cross-talk between GPCR and a variety of signaling pathways through assembling multiple protein complexes (e.g., RAF/MEK/ERK1/2) in the cytoplasm (Shenoy and Lefkowitz, 2005) . Our recent study showed that under d-or kopioid receptor stimulations, nuclear b-arrestin1 specifically accumulates at p27 and c-fos promoters through scaffolding CREB and histone acetyltransferase p300, thus enhancing local histone H4 acetylation and gene transcription (Kang et al., 2005) .
A similar mechanism was also observed during T cell activation, in which nuclear b-arrestin1 increases Bcl-2 expression and contributes to CD4 + T cell survival (Shi et al., 2007) . These observations demonstrated that nuclear b-arrestin1 plays an important role in signal transduction and transcription regulation (Berghmans et al., 2005) , however, the underlying mechanisms and physiological significance remain to be elucidated (Beaulieu and Caron, 2005) . Spatial and temporal gene expression is strictly controlled during vertebrate development (Reik, 2007) , but the potential roles of b-arrestins during this process have long been elusive. Targeted deletion of either b-arrestin1 or b-arrestin2 in mice does not affect their viability, however, double knockout of these two proteins induces perinatal death due to multiple organ failures (our unpublished data). This implies that b-arrestin1 and b-arrestin2 may have important but largely redundant functions during mammalian development. Previously, b-arrestin2 was shown to be essential for zebrafish embryogenesis (Wilbanks et al., 2004) , while the information of b-arrestin1 is still lacking, indicating that zebrafish may serve as an ideal model to study the function of b-arrestin1 in vertebrate development.
Hematopoiesis is a dynamic process involving the interplay between lineage-specific transcription factors and epigenetic regulators (Rice et al., 2007) . Two waves of hematopoiesis, namely, primitive and definitive hematopoiesis, occur sequentially in the intermediate cell mass (ICM) and aorta-gonad-mesonephros (AGM) region during zebrafish development (Orkin and Zon, 2008) . Previous studies have shown that transcription factors cdx4 and cdx1a, which belong to the caudal family of homeobox-containing genes, play critical roles in the specification of hematopoietic lineage through direct hox gene regulation. Zebrafish embryos depleted of cdx4 and/or cdx1a display severe hematopoietic defects, as well as aberrant expression of posterior hox genes (Davidson et al., 2003; Davidson and Zon, 2006) . Importantly, injection of hoxa9a or hoxb7a mRNA partially rescued those hematopoietic defects, thus establishing the critical role of cdx-hox pathway in primitive hematopoiesis. Similarly, ectopic expression of Cdx4 and/or HoxB4 in murine embryonic stem cells promotes in vitro hematopoietic lineage differentiation, whereas Cdx genes deficiency significantly compromises this process Wang et al., 2008b; Wang et al., 2005) . Previously, Wnt signaling and the transcription factor Mespa have been implicated in the regulation of cdx4-hox pathway in zebrafish (Hart et al., 2007; Lengerke et al., 2008) , but whether epigenetic mechanisms could be involved remains unknown. Recently, a histone H3 lysine 27 demethylase UTX was discovered and proven to be essential for the posterior development of zebrafish embryos, probably through regulating the expression of hox genes (Lan et al., 2007) . This raises the possibility that histone modifications such as H3 lysine 27 methylation may participate in the regulation of cdx-hox pathway and zebrafish hematopoiesis.
Polycomb group (PcG) proteins are evolutionarily conserved transcriptional repressors critically involved in the maintenance of Hox gene expression patterns along the anterior-posterior axis (Ringrose and Paro, 2004) . Two classical polycomb repressive complexes, namely PRC1 and PRC2, repress gene transcription through catalyzing mono-ubiquitination of histone H2A (ubH2A) and tri-methylation of histone H3 Lysine 27 (H3K27me3) in the promoter region of their target genes. Recently, a third complex PhoRC, which contains the DNAbinding protein Pho/YY1, was identified and shown to recruit PRC1 and/or PRC2 to target DNA sequence (Schuettengruber et al., 2007) . In contrast to Drosophila, where PcG target sites are constitutively bound throughout development (Negre et al., 2006) , binding of PcG proteins to their target genes appears more dynamic in vertebrates. In mouse and human embryonic stem cells, PcG proteins preferentially bind to the promoter regions of developmental regulators, including many homeodomain-containing transcription factors, and repress their expression through catalyzing the H3K27me3 modification. Once differentiated, these target genes are activated, concomitant with the loss of PcG proteins Lee et al., 2006) . However, the mechanism by which PcG proteins are dynamically regulated is largely unknown. In this study, we found that b-arrestin1 is critically involved in zebrafish primitive hematopoiesis, where b-arrestin1 binds to and sequesters the PcG recruiter YY1, thus relieving PcG-mediated repression of cdx4-hox pathway.
RESULTS

Identification of b-Arrestin1 as An Evolutionarily Conserved Protein in Zebrafish
Previously, zebrafish b-arrestin2 was identified and shown to modulate the Hedgehog pathway (Wilbanks et al., 2004) . However, whether b-arrestin1 exists in zebrafish is still unknown. In the present study, we first cloned the full-length zebrafish b-arrestin1 using 5 0 and 3 0 rapid amplification of cDNA ends (RACE). Zebrafish b-arrestin1 contains 418 amino acids, which displays 90% (379/418) identities and 96% (404/418) similarities to human and mouse b-arrestin1 (see Figure S1A and Table S1 available online). As evident from the phylogenetic tree and genomic structure analysis, zebrafish b-arrestin1 is closely related to its mammalian homologs ( Figures 1A and 1B) . Similar to human b-arrestins, zebrafish b-arrestin1 resides in both the nucleus and cytoplasm, while b-arrestin2 mainly localizes in the cytoplasm under steady state (Figures S1B-S1E). Next, we analyzed the developmental expression of b-arrestin1 using antibody staining, quantitative real-time PCR (qPCR) and wholemount in situ hybridization (WISH) technologies, which showed that zebrafish b-arrestin1 was expressed both maternally and zygotically throughout early development, with relative enrichment in the eyes and brain at later stages .
To elucidate the function of b-arrestin1 during zebrafish development, anti-sense morpholino oligonucleotides were designed to specifically block the translation of b-arrestin1 mRNAs. Morpholino against zebrafish visual-arrestin was used as a negative control (Wilbanks et al., 2004) , and depletion of b-arrestin1 was confirmed by western blot in embryos injected with 4 ng of b-arrestin1 morpholino ( Figure 1D ). b-arrestin1 morphants developed normally until 12 hr post fertilization (hpf), showing delayed elongation of the tail ( Figures S2B and S2E ). Significant abnormalities could be observed at 24 hpf, including shortened body length, moderate necrosis in the anterior region and ventrally curved tail ( Figures 1E and S2H) . Importantly, the developmental defects of b-arrestin1 morphants could be rescued by coinjection of human b-arrestin1 mRNA, further supporting the specificity of the morpholino and functional conservation of this protein ( Figures 1E and 1F ). Taken together, we identified b-arrestin1 as an evolutionarily conserved protein in zebrafish.
Critical Role of b-Arrestin1 in Zebrafish Hematopoiesis
To further explore the role of b-arrestin1 in zebrafish, developmental marker genes were analyzed using WISH. As controls, embryos depleted of b-arrestin2 were also analyzed (Figures S2C, S2F and S2I) . Consistent with previous studies (Chen et al., 2004; Wilbanks et al., 2004) , ptc1, a downstream target gene of Hedgehog signaling, was significantly disrupted in b-arrestin2, but not b-arrestin1-deficient embryos ( Figures  2A-2C , n = 20/38). The cardiac mesodermal marker nkx2.5 was decreased in both b-arrestin1 and b-arrestin2-deficient embryos, suggesting common roles of b-arrestins in heart development ( Figures 2D-2F , n E = 33/35, n F = 22/36). Interestingly, the early hematopoietic and vascular progenitor markers lmo2 and fli1 were markedly reduced in b-arrestin1 but not b-arrestin2 morphants ( Figures 2G-2I , n = 48/51; Figures 2J-2L, n = 36/ 40), suggesting specific function of b-arrestin1 during primitive hematopoiesis. Besides, hematopoietic progenitor markers runx1 and cmyb were also analyzed, which displayed similar reduction in b-arrestin1 morphants ( Figures S3A-S3C , n = 36/ 42; Figures S3D-S3F , n = 43/52). In contrast, the ventral marker bmp4 ( Figures 2M-2O) , the pronephric and midbrain-hindbrain boundary marker pax2.1 ( Figures S3G-S3I and S4A-S4C), as well as the neural markers pax6a and otx2 ( Figures S4D-S4F and S4G-S4I) remained unaffected in both morphants.
To comprehensively understand the distinctive roles of b-arrestin1 and b-arrestin2 during zebrafish development, microarray analysis was performed at 12 hpf. Depletion of b-arrestin1 affected a larger set of genes than b-arrestin2, while double depletions induced even more gene expression changes (Figure 2P) . Notably, few target genes were shared by these two proteins, and cluster analysis clearly distinguished b-arrestin1 from b-arrestin2 ( Figure 2Q ). Consistent with the WISH results, most of the hematopoietic marker genes were found to be specifically downregulated in b-arrestin1 but not b-arrestin2 morphants ( Figure 2R ; Supplemental spreadsheets list all genes regulated), which could be verified by qPCR analysis ( Figure  2S ). These findings suggested that b-arrestin1 and b-arrestin2 have distinctive functions during zebrafish development, and that b-arrestin1 may specifically participate in zebrafish hematopoiesis. To substantiate the function of b-arrestin1 in zebrafish hematopoiesis, we examined additional hematopoietic markers using WISH. At 13 hpf, the early marker of hematopoietic precursors, scl, was markedly reduced in both the anterior-and posteriorlateral plate mesoderm (A-LPM and P-LPM) (Figures 3A and 3B, n = 53/57). In addition, the primitive erythroid marker gata1 and the myeloid progenitor marker pu.1 significantly decreased in b-arrestin1 morphants, implicating that the development of erythroid and myeloid lineages were both impaired ( Figures It has been shown that hematopoietic cells in the P-LMP migrate toward the midline to form intermediate cell mass (ICM) after 20 hpf, where primitive erythropoiesis mainly takes place. By 24 hpf, the ICM markers scl and lmo2 decreased dramatically in b-arrestin1 morphants (Figures 3G and 3H, n = 33/35; Figures 3K and 3L, n = 24/29) , while the erythroid progenitors and mature erythrocyte markers gata1 and hbbe3 nearly diminished ( Figures 3M and 3N , n = 27/27; Figures 3I and 3J, n = 18/21). In addition, depletion of b-arrestin1 in the hematopoietic Tg(lmo2:Dsred) (Wang et al., 2008a) and Tg(gata1:EGFP) (Fu et al., 2008) To determine whether the defects caused by b-arrestin1 morpholino are cell autonomous or not, blastula transplantation experiment was performed. We used Tg(gata1:EGFP) transgenic embryos as the donor and transplanted about 30 cells to wildtype embryos at late blastula stage. As indicated by EGFP fluorescence in wild-type embryos at 24 hpf, significant amount of donor cells differentiated into gata1 + hematopoietic cells in the ICM regions when injected with control morpholino but not b-arrestin1 morpholino ( Figures S6A-S6D , n = 13; Figures S6E-S6H, n = 7). Consistently, donor cells injected with control morpholino differentiated into gata1 + hematopoietic cells normally when transplanted into b-arrestin1 morphants (Figures S6I-S6L , n = 10), further demonstrating that the defects observed are cell autonomous effects ( Figure S6M ). Collectively, these results provide strong evidence supporting that b-arrestin1 plays a critical role during zebrafish primitive hematopoiesis.
Cdx4-Hox Pathway Lies Downstream of b-Arrestin1
The phenotypes and hematopoietic defects of b-arrestin1 morphants were reminiscent of embryos depleted of cdx4 ( Figures S7A and S7B , n = 165/ 171; Davidson et al., 2003) , a caudaltype homeobox transcription factor that specifies hematopoietic lineage through modulating posterior hox gene expression. Thus, we reasoned that cdx4-hox pathway may lie downstream of b-arrestin1 during zebrafish hematopoiesis. Consistent with our hypothesis, WISH results revealed that depletion of b-arrestin1 decreased the expression of cdx4 ( Figures 4A and 4B , n = 35/44), but not cdx1a (data not shown). Besides, hox genes downstream of cdx4, including hoxa9a ( Figures 4C and 4D , n = 46/52), hoxb4a ( Figures 4E and 4F , n = 46/48), hoxb7a ( Figures 4G and 4H , n = 34/56), hoxb5a ( Figures  S7C and S7D , n = 40/58) and hoxb6b ( Figures S7E and S7F , n = 41/66), were all significantly reduced in b-arrestin1 morphants. Subsequent qPCR analysis not only confirmed these WISH results ( Figure S7G ), but also showed that most of the hox genes in zebrafish were downregulated by depletion of b-arrestin1, suggesting that b-arrestin1 functions as an important regulator of hox genes ( Figure S7H ).
When using gata1 and scl as functional read-outs, injection of cdx4 ( Figures 4K and 4P , n K = 40/41, n P = 35/41) mRNAs restored their expression pattern in b-arresetin1 morphants, although the tail defects were not completely rescued (data not shown). Similarly, injection of hoxa9a ( Figures 4L and 4Q , n L = 43/54, n Q = 34/42) or hoxb4a ( Figures 4M and 4R , n M = 42/ 43, n R = 43/46) mRNA also restored the expression of gata1 and scl to various extent. Moreover, injection of hoxa9a morpholino mimicked the phenotypes of b-arrestin1 morphants ( Figures  S7I-S7M ), while hoxb4a morpholino may induce nonspecific phenotypes via p53 activation (Figures S7N-S7R ). Taken together, these results suggested that in the absence of b-arrestin1, cdx4-hox pathway is disrupted, leading to the observed hematopoietic defects.
b-Arrestin1 Functionally Interacts with PcG Protein YY1 Previously, Wnt signaling and transcription factor Mespa were shown to modulate cdx4-hox pathway in zebrafish (Hart et al., 2007; Lengerke et al., 2008; Shimizu et al., 2005) . However, depletion of b-arrestin1 affected neither the expression of vox and tbx6, two classical Wnt signaling targets ( Figures S8A-S8D ), nor that of mespa (data not shown), suggesting that Wnt signaling and Mespa may be not involved in b-arrestin1-initiated zebrafish hematopoiesis. Since b-arrestin1 regulates signal transduction and gene transcription mainly through protein interactions (Gao et al., 2004; Wang et al., 2003) , we decided to screen b-arrestin1 interacting partners using yeast two-hybrid system. We paid special attention to those factors critically involved in hox gene regulation as well as hematopoiesis, and finally identified YY1 (Erkeland et al., 2003; Raich et al., 1995) . YY1 is a ubiquitously expressed transcription factor essential for embryonic development (Donohoe et al., 1999) . Besides, it is also identified as an evolutionarily conserved PcG protein critically involved in DNA binding, and recruitment of PRC1 and/or PRC2 complexes to hox gene promoters (Atchison et al., 2003; Kim et al., 2006) . Bio-informatic analysis revealed that several YY1-specific motifs present in the promoter regions of cdx4 and its downstream hox genes, which suggests that the interaction between b-arrestin1 and YY1 may contribute to the regulation of cdx4-hox pathway.
Coimmunoprecipitation assay confirmed that b-arrestin1 interacts with YY1, but not with another PcG protein Ring1A ( Figure 5A ). Interaction between endogenous b-arrestin1 and YY1 was also seen when using YY1 specific antibody in human MCF-7 cells ( Figure 5B ). Moreover, zebrafish b-arrestin1 and YY1, when coexpressed in HEK293 cells, also interacts with each other, demonstrating the evolutionary conservation of this interaction ( Figure 5C , lane 1 and lane 2). To ascertain the significance of this interaction, we screened the binding mutants using both bio-informatic calculation and truncation analysis. Consistent with the fact that YY1 is a highly positive charged protein, the extreme C-terminal region of b-arrestin1, which is enriched with negative charge amino acids, is critical for its interaction with YY1 (Figures S9A). Point mutation analyses revealed that b-arrestin1 D383, 384, 385 A, E404, 405, 406, 407A (designated as 7M b-arrestin1) had very little, if any, interaction with YY1 ( Figure 5C ), as was the case for its human ortholog ( Figure 5D ). In addition, confocal microscope showed that in HEK293 cell lines stably expressing single copies of b-arrestin1 ( Figure S10A ), wild-type but not 7M b-arrestin1 could colocalize with YY1 in the cytoplasm (Figures S10B-S10I) . Nevertheless, like wild-type b-arrestin1, 7M b-arrestin1 showed normal interaction with known b-arrestin1 partners ( Figure S9B) , and retained classical functions of b-arrestin1, such as ERK activation and receptor internalization ( Figures S9C and data not shown) , implicating that 7M b-arrestin1 is a functionally active mutant.
To explore the significance of b-arrestin1-YY1 interaction in vivo, we injected GFP-tagged zebrafish YY1 mRNA into onecell stage embryos, and observed its sub-cellular localization during development. YY1 mainly localized in the nucleus before 12 hpf (Figures 5E-5J ), but gradually translocated into the cytoplasm during segmentation periods (Figures 5K-5R) . Importantly, coinjection of b-arrestin1 morpholino inhibited the cytoplasmic translocation of YY1, leading to significant nuclear accumulation ( Figures 5S-5V) . Collectively, these results showed that b-arrestin1 interacts with YY1 and may negatively regulate its function through affecting its cytoplasmic translocation.
b-Arrestin1 Relieves PcG Repression and Regulates Hematopoietic Lineage Specification
To provide direct evidence for the regulation of cdx4-hox pathway by b-arrestin1-YY1 interaction, whole-embryo chromatinimmunoprecipitation (E-ChIP) was performed. Depletion of b-arrestin1 led to increased binding of YY1 to cdx4, hoxa9a and hoxb4a promoter regions, while coinjection of wild-type, but not 7M b-arrestin1 mRNA, could reverse this trend (Figure 6A) . To test whether YY1-mediated PcG protein recruitment is responsible for cdx4-hox pathway repression, promoter occupancy of PRC2 core component Suz12, the corresponding repressive histone modification H3K27me3, as well as the transcriptional active histone modification H3K4me3 were analyzed using E-ChIP. Similar to YY1, depletion of b-arrestin1 led to increased Suz12 binding, elevated level of H3K27me3 and concomitantly decreased level of H3K4me3 at cdx4, hoxa9a and hoxb4a promoter regions, which could be rescued by injection of wild-type, but not 7M b-arrestin1 mRNA (Figures 6B-6D ). Promoter occupancy of the PRC1 core component Bmi1 was also analyzed and revealed no significant changes for these genes ( Figure S11) .
Consistent with the E-ChIP results, injection of wild-type human b-arrestin1 mRNA rescued the posterior defects of b-arrestin1 deficient embryos ( Figure 6E) , and restored the expression of cdx4 ( Figure 6G , n = 48/56), gata1 ( Figure 6J , n = 52/60) and scl ( Figure 6M , n = 41/58), while 7M b-arrestin1 mRNA fail to show any rescue effects ( Figures 6E, 6H, 6K, and  6N) . Moreover, depletion of either YY1 or Suz12 using morpholinos could largely rescue b-arrestin1 morphant phenotypes ( Figures S12A-S12C) , and restore normal expression of hematopoietic marker genes ( Figures S12D-S12I ), further supporting that YY1/Suz12 recruitment repress cdx4-hox pathway activation.
To detect the upstream signal of b-arrestin1 during hematopoiesis and cdx4-hox regulation, we used small-molecule inhibitors to block different signaling pathways, and observed the subcellular localization changes of YY1 in zebrafish embryos. At 24 hpf, inhibition of the Hedgehog pathway (Cyclopamine, Figures S13E-S13H ), Notch pathway (DAPT, Figures S13I-S13L ) or RA pathway (DEAB, Figures S13M-S13P) did not affect the distribution of YY1, as compared with DMSO treated embryos ( Figures S13A-S13D ). In contrast, blockage of the FGF pathway significantly inhibited the cytoplasmic translocation of YY1, leading to its nuclear accumulation and a phenotype reminiscent of b-arrestin1 morphants (SU5402, Figures S13Q-S13T, and data not shown). Consistently, FGF signaling has been shown to regulate cdx4-hox pathway in both Xenopus and zebrafish, while the mechanisms of which remain unclear (Keenan et al., 2006; Shimizu et al., 2005) . Thus, our findings may suggest a potential role of b-arrestin1 during this process. Collectively, these data revealed a model in which b-arrestin1 sequesters YY1 and relieves the potential repression of cdx4-hox pathway by PcG proteins, thus regulating hematopoietic lineage specification.
DISCUSSION
b-Arrestin1 plays critical roles in signal transduction and epigenetic regulation of gene transcription. In this study, we uncovered that b-arrestin1 is essential for zebrafish development and critically involved in primitive hematopoiesis. Importantly, b-arrestin1 was found to sequester the PcG recruiter YY1 and relieve PcG-mediated repression of cdx4-hox pathway, thus specifying hematopoietic lineage commitment. Collectively, our data shed light on a previously unexpected role of b-arrestin1 in zebrafish hematopoiesis, as well as a key regulator of PcG proteins and cdx4-hox pathway.
The developmental role of b-arrestins has long been underestimated, since mice with targeted deletion of either b-arrestin1 or b-arrestin2 show no obvious defects. Although studies with cell culture models suggested potential roles of b-arrestins in Figure 6 . b-Arrestin1 Relieves PcG Repression and Regulates Hematopoietic Lineage Specification (A-D) Whole-embryo chromatin immunoprecipitation (E-ChIP) assays at 12 hpf. Embryos injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1 morpholino (Arrb1 MO), 4 ng b-arrestin1 morpholino plus 100 pg human b-arresetin1 mRNA (hArrb1 mRNA) or 4 ng b-arrestin1 morpholino plus 100 pg human 7M b-arrestin1 mRNA (hArrb1 7M mRNA) were probed with antibodies against YY1 (A), Suz12 (B), H3K27me3 (C) and H3K4me3 (D). The presence of cdx4, hoxa9a, hoxb4a and cdx1a promoter sequences in the input DNA and antibody-bound chromatin segments was analyzed by qPCR. The data obtained were normalized on the basis of the corresponding input control, and means ± SEM from three independent experiments were plotted, *p < 0.05, **p < 0.01, ***p < 0.001 versus the control morpholino group. Primer sets covering different regions of the same promoter were used and produced similar results. (E) Phenotypic analyses of embryos at 26 hpf. Embryos injected as (A)-(D) were analyzed. (F-N) Whole-mount in situ hybridization for embryos at 12 hpf. Embryos injected as in (E) were hybridized with riboprobes to cdx4 (F-H), gata1 (I-K) and scl (L-N).
developmental regulation, in vivo evidences are still lacking. Our results in zebrafish, together with previous study of zebrafish b-arrestin2 (Wilbanks et al., 2004) , provide strong evidence supporting that both b-arrestin1 and b-arrestin 2 function as important regulators during vertebrate development. The different scenarios in mouse and zebrafish could be explained by the functional redundancy between the two proteins. In contrast to their mammalian homologs, zebrafish b-arrestin1 and b-arrestin2 appear to have largely nonredundant functions, since depletion of either protein induces significant and distinctive developmental defects. b-arrestin1 seems to play a more important role during zebrafish development, probably due to its nuclear localization ability ( Figure S2 ; Kang et al., 2005) . Previously, zebrafish Cox1 and Cox2, two major prostaglandin synthase, were shown to play critical roles in hematopoietic stem cell (HSC) induction (North et al., 2007) , while Cox1 or Cox2 knockout mice are viable and show no apparent defects in HSC formation (Lorenz et al., 1999) . Nevertheless, Cox2 knockout mice demonstrated alterations in hematocrit levels and impaired recovery from 5-FU-induced bone marrow injury. Similarly, b-arrestin1 knockout mice also display significant basal hematology defects (our unpublished data), implicating a potential role of b-arrestin1 in mammalian hematopoiesis. Different challenging conditions (e.g., 5-FU or phenylhydrazine treatment) could be explored to fully understand the function of b-arrestin1 during mammalian development.
Vertebrate hematopoiesis is a complex and coordinated process involving dynamic regulation and multiple signaling pathways (Orkin and Zon, 2008; Rice et al., 2007) . In zebrafish, cdx4-hox pathway was demonstrated to be critical for embryonic blood formation, but the upstream signaling controlling its developmental expression remain unclear. In this study, we demonstrated that PcG protein recruitment and the subsequent H3K27me3 modification represents an important repressive mechanism of cdx4-hox pathway, while the correct expression of b-arrestin1 is critical for relieving PcG repression and cdx4-hox pathway activation. Notably, the genes affected by this mechanism may not be restricted to cdx4-hox pathway, since most of the hox genes were downregulated by b-arrestin1 depletion ( Figure S7H ). Besides, we also analyzed the expression levels and promoter status of classical PRC2 target genes (extracted by homology to mammalian targets) wnt1 and hoxa10b (Cao et al., 2008; Kirmizis et al., 2004) , and found that these genes were also significantly downregulated in b-arrestin1 morphants ( Figure S14A ), concomitant with increased YY1/Suz12 binding and elevated H3K27me3 levels on their promoter regions. Similarly, coinjection of wildtype, but not 7M b-arrestin1 mRNA, could reverse this trend ( Figures S14B-S14D ). Future genome-wide location analysis will be helpful to comprehensively explore the genes regulated by b-arrestin1 and PcG proteins during vertebrate development. Finally, the discovery that b-arrestin1-mediated YY1 translocation could be affected by FGF signaling is rather interesting, especially because cdx4-hox pathway has been subjected to the regulation by FGF signaling (Keenan et al., 2006; Shimizu et al., 2005) . Thus, b-arrestin1 may mediate the response of cdx4-hox pathway to extracellular signals such as FGF.
PcG proteins play fundamental roles in vertebrate development and numerous biological processes. Sequence specific factors, including GAF and PHO/YY1, have been proposed to recruit polycomb complexes to target gene promoters, leading to epigenetic silencing of gene expression (Atchison et al., 2003; Horard et al., 2000; Mohd-Sarip et al., 2005) . However, the mechanisms by which PcG proteins are excluded from their target sites remain poorly understood. In this study, we identified b-arrestin1 as an important negative regulator of PcG proteins through affecting the translocation of YY1, which provides a novel mechanism of PcG regulation. Previously, Xenopus YY1 was found to be retained in the cytoplasm during early development, the mechanism and functional significance of which remains elusive (Ficzycz et al., 2001 ). Our results demonstrated that interaction with b-arrestin1 may lead to decreased level of YY1 in the nucleus, concomitant with the absence of PcG proteins and repressive marks at specific gene promoters, thus leading to the activation of cdx4-hox pathway. Interestingly, recent studies in embryonic stem cells (ESCs) revealed that sequestration of PcG complexes from developmental regulators contributes to differentiation Boyer et al., 2006) . Thus, our studies in zebrafish imply a potential role of b-arrestin1 in PcG protein regulation during ESCs differentiation.
In summary, this study unravels the developmental function of b-arrestin1 and further illustrates the mechanism by which b-arrestin1 participates in epigenetic regulation. The finding that b-arrestin1 functions as an important regulator of PcG proteins will be of great significance to the study of PcG-mediated epigenetic regulation. The challenge for future studies will be to better understand the mechanisms of PcG regulation by b-arrestin1 in ESCs, as well as its relevance to hematopoietic diseases such as leukemia and anemia.
EXPERIMENTAL PROCEDURES Zebrafish Maintenance and Embryo Production
Zebrafish maintenance, breeding, and staging were performed as described previously (Kimmel et al., 1995) .
Cloning of Zebrafish b-Arrestin1
Total RNA of 120 hpf zebrafish was extracted with Trizol Reagent (Invitrogen Life Technology), and reverse-transcribed using BD SMART RACE kit (TAKARA). For 3 0 RACE, 3 0 RACE CDS primer A and GSP1 (5 0 -atgggaga taaaggcacaagggtgttcaa-3 0 ) were used. For 5 0 RACE, BD SMART II A Oligonucleotide and GSP2 (5 0 -cctcaggcactcagtggacgcctatcaa-3 0 ) were used. The PCR products were cloned into TA vector and sequenced, which has been submitted to GeneBank (DQ508020).
Morpholino, mRNA Synthesis and Microinjection
Morpholino antisense oligonucleuotides (MO) were obtained from Gene Tools, LLC. Visual-arrestin MO, b-arrestin2 MO and cdx4 MO have been described previously (Wilbanks et al., 2004; Davidson et al., 2003) . The sequence information of other morpholinos is provided in Table S2 . To generate mRNAs, full-length b-arrestin1 (human), cdx4, hoxa9a, and hoxb4a genes were subcloned into pCDNA3 vector (cloning primer sequences are listed in Table S3 ), and synthesized using the mMessage mMachine kit (Ambion). For all the microinjection experiments, a volume of 1 nl was injected into one-to two-cell stage embryos.
Riboprobe Synthesis and Whole Mount in situ Hybridization
Antisense riboprobes were synthesized using the DIG RNA Labeling kit (Roche) according to the manufacturer's instructions. WISH was carried out as described previously (Gan et al., 2008) , and staining was performed with an alkaline phosphatase substrate kit (SK-5400, Vector Laboratories, Inc.).
Microarray Analysis
Fifty embryos injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1 morpholino (Arrb1 MO), 4 ng b-arrestin2 morpholino (Arrb2 MO), or 4 ng b-arrestin1 morpholino plus 4 ng b-arrestin2 morpholino (Double MO) were lysed in Trizol reagent at 12 hpf. Total RNA were extracted and labeled with Cy3. Samples were then hybridized onto Zebrafish Oligo Microarray (G2519F, 4 3 44K, Design ID: 019161) purchased from Agilent Tech. Slides were washed according to standardized protocol form Agilent Tech, and scanned using a G2565BA Microarray Scanner System (Agilent). Data were analyzed using GeneSpring GX software 7.3 (Agilent). The threshold of the level of changed genes was set at two folds. (sc-7341; Santa Cruz) in human MCF7 cells, followed by incubation with 20 ml proteinA-agarose beads (Sigma) overnight. Immunoprecipitants and 5% total lysates were denatured in loading buffer supplemented with 1% BME, separated on 15% SDS-PAGE and transferred to nitrocellulose membranes. Blots were probed with anti-HA and anti-Flag, or with A1CT and anti-YY1 antibodies for endogenous interaction assay. The membrane was detected by secondary fluorescent rabbit antibody CW800.
Real-Time Quantitative PCR Total RNAs were extracted from 20 zebrafish embryos (12 hpf) using Trizol reagent (Sigma). RNA was reverse-transcribed using random hexamers and M-MLV Reverse Transcriptase (Promega). 23 PCR Mix (Tiangen) and Eva Green (Biotium) were used for the real-time quantitative PCR analysis, with an MX3000P Stratagene PCR machine. The relative expression values were normalized against the internal control gapdh (RT-PCR primer sequences were listed in Table S3 ).
Embryonic Chromatin Immunoprecipitation (E-ChIP) E-ChIP was performed as previously described with modifications (Wardle et al., 2006) . Please see details in Supplemental Data.
Fluorescence Microscopy HEK293 cells were split onto coverslips in 6-well plate and cultured for 48 hr. Cells were fixed, permeabilized and stained with respective antibodies. Images were acquired using Leica TCS SP2 confocal fluorescence microscopy. For zebrafish antibody staining, embryos were harvested at indicated time points, fixed and permeabilized, followed by antibody staining using A1CT or anti-GFP antibody. Secondary antibodies conjugated to Cy3 or Alexa-488 were used for b-arrestin1 and YY1 staining, respectively. Images were acquired using Olympus SZX16 system or Olympus confocal microscopy.
O-dianisidine Staining
Embryos wee dechorionated with pronase at 36 or 72 hpf, and stained with 1 ml staining buffer (O-dianisidine 0.6 mg/ml; 0.01 M NaAc, [pH 4.5]; 0.65% hydrogen peroxide; 40% ethanol), flowed by incubation in the dark for 15 min and stop by adding PBST. Images were acquired using Olympus SZX16 system, and analyzed with Image-pro plus software.
Blastula Transplantation Assay Tg(gata1:EGFP) transgenic embryos were used as donors and were injected with 4 ng control MO or Arrb1 MO, as well as the tracer dye Dextran568 at one-cell stage. Wild-type embryos without treatment, or injected with 4 ng Arrb1 MO were used as hosts. Embryos were dechorioned by forceps and deposited at ramps at sphere stage (4 hpf). About 30 donor cells were transplanted into host embryos at lateral blastoderm near the margin region, from which blood and vascular cells derived. Embryos were subsequently grown in 0.33 Danieau's buffer at 28.5 C until 24 hpf. The embryos showing EGFP expression were picked out under fluorescent stereoscope, and mounted in 1.0% low-melt agarose for imaging with confocal microscopy.
Treatment of Embryos with Small-Molecule Inhibitors
Small-Molecule inhibitors dissolved in DMSO were added into fish facility water as previously reported: Cyclopamine (100 mM, 5.5 hpf-90% epiboly); DAPT (100 mM, 4 hpf-24hpf); DEAB (50 mM, 6 hpf-24 hpf) and SU5402 (25 mM, 6 hpf-24 hpf).
Statistical Analysis
Quantitative data are expressed as mean ± SEM. Statistical significance was determined by one-way analysis of variance followed by the LSD post hoc test for multiple comparisons. p value of less than 0.05 was considered statistically significant.
ACCESSION NUMBERS
The GEO accession number for the microarray study is GSE17773.
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